Document

Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-TS25-036, Identify and Evaluate Potential Risk Factors for ALS; Amended Notice of Closed Meeting

Department of Health and Human Services Centers for Disease Control and Prevention AGENCY: Centers for Disease Control and Prevention, Department of Health and Human Services. A...

Department of Health and Human Services
Centers for Disease Control and Prevention

AGENCY:

Centers for Disease Control and Prevention, Department of Health and Human Services.

ACTION:

Notice.

FOR FURTHER INFORMATION CONTACT:

Carlisha Gentles, Pharm.D., B.C.P.S., C.D.C.E.S., Scientific Review Officer, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, 4770 Buford Highway NE, Mailstop S106-9, Atlanta, Georgia 30341. Telephone: (770) 488-1504; Email: .

SUPPLEMENTARY INFORMATION:

Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—TS25-036, Identify and Evaluate Potential Risk Factors for ALS; February 25-26, 2025, 10 a.m.-5 p.m., EST, web conference, in the original Federal Register notice. The meeting notice was published in the Federal Register on December 2, 2024, 89 FR 95215.

This meeting notice is being amended to change the meeting dates from a two-day meeting to a one-day meeting. The notice should read as follows:

Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—TS25-036, Identify and Evaluate Potential Risk Factors for ALS.

Date: February 25, 2025.

Time: 10 a.m.-5 p.m., EST.

The meeting is closed to the public.

The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,

Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.

[FR Doc. 2024-29009 Filed 12-10-24; 8:45 am]

BILLING CODE 4163-18-P

Legal Citation

Federal Register Citation

Use this for formal legal and research references to the published document.

89 FR 99871

Web Citation

Suggested Web Citation

Use this when citing the archival web version of the document.

“Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-TS25-036, Identify and Evaluate Potential Risk Factors for ALS; Amended Notice of Closed Meeting,” thefederalregister.org (December 11, 2024), https://thefederalregister.org/documents/2024-29009/disease-disability-and-injury-prevention-and-control-special-emphasis-panel-sep-ts25-036-identify-and-evaluate-potential.